Zoledronic Acid Inhibits Lipopolysaccharide-Induced Osteoclastogenesis by Suppressing Macrophage NLRP3-Mediated Autophagy Pathway. [PDF]
Cheng Y +9 more
europepmc +1 more source
Zoledronic acid increases spine bone mass and prevents hip bone loss after bariatric surgery: a randomized placebo-controlled study. [PDF]
Gam S +6 more
europepmc +1 more source
A Comparison of the Efficacy and Safety of Denosumab and Zoledronic Acid in Patients with Bone Metastatic Breast Cancer Receiving CDK4/6 Inhibitor Therapy. [PDF]
Öner İ +6 more
europepmc +1 more source
Comparison of patients with myeloma receiving zoledronic acid vs denosumab: a nationwide retrospective cohort study. [PDF]
Mohyuddin GR +8 more
europepmc +1 more source
Effect of Local Zoledronic Acid Application in Alveolar Bone Healing: An Experimental Study. [PDF]
Su XY, Li S, Fan YY, Wei T, Lu ZY, Ye P.
europepmc +1 more source
Zoledronic acid as adjuvant therapy in neovascular age-related macular degeneration: a randomised controlled pilot study. [PDF]
Husum YS +4 more
europepmc +1 more source
Novel combined pharmacological strategy to alleviate acute phase response following zoledronic acid treatment. [PDF]
Chen CH +11 more
europepmc +1 more source

